Dai-ichi Life Insurance Company’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.45M | Hold |
12,275
| – | – | 0.03% | 315 |
|
|
2026
Q1 | $1.47M | Hold |
12,275
| – | – | 0.04% | 290 |
|
|
2025
Q4 | $1.67M | Hold |
12,275
| – | – | 0.04% | 296 |
|
|
2025
Q3 | $1.81M | Hold |
12,275
| – | – | 0.05% | 284 |
|
|
2025
Q2 | $1.59M | Sell |
12,275
-3,919
| -24% | -$475K | 0.04% | 290 |
|
|
2025
Q1 | $1.93M | Hold |
16,194
| – | – | 0.06% | 268 |
|
|
2024
Q4 | $1.88M | Sell |
16,194
-4,000
| -20% | -$506K | 0.05% | 296 |
|
|
2024
Q3 | $2.73M | Sell |
20,194
-58,159
| -74% | -$7.78M | 0.07% | 240 |
|
|
2024
Q2 | $10.6M | Sell |
78,353
-38,534
| -33% | -$5.24M | 0.26% | 100 |
|
|
2024
Q1 | $2.32M | Sell |
116,887
-2,182
| -2% | -$264K | 0.05% | 284 |
|
|
2023
Q4 | $13.6M | Buy |
+119,069
| New | +$11.9M | 0.28% | 82 |
|
|
2023
Q3 | – | Sell |
-14,004
| Closed | -$1.58M | – | 491 |
|
|
2023
Q2 | $1.58M | Buy |
14,004
+12,000
| +599% | +$1.27M | 0.03% | 319 |
|
|
2023
Q1 | $210K | Hold |
2,004
| – | – | ﹤0.01% | 467 |
|
|
2022
Q4 | $222K | Sell |
2,004
-13,000
| -87% | -$1.36M | 0.01% | 474 |
|
|
2022
Q3 | $1.31M | Buy |
+15,004
| New | +$1.36M | 0.03% | 343 |
|
|
2022
Q1 | – | Sell |
-2,004
| Closed | -$240K | – | 543 |
|
|
2021
Q4 | $240K | Hold |
2,004
| – | – | ﹤0.01% | 507 |
|
|
2021
Q3 | $248K | Hold |
2,004
| – | – | ﹤0.01% | 519 |
|
|
2021
Q2 | $240K | Hold |
2,004
| – | – | ﹤0.01% | 533 |
|
|
2021
Q1 | $211K | Hold |
2,004
| – | – | ﹤0.01% | 538 |
|
|
2020
Q4 | $204K | Buy |
+2,004
| New | +$188K | ﹤0.01% | 512 |
|
|
2020
Q1 | – | Sell |
-2,560
| Closed | -$202K | – | 540 |
|
|
2019
Q4 | $202K | Hold |
2,560
| – | – | ﹤0.01% | 529 |
|
|
2019
Q3 | $204K | Hold |
2,560
| – | – | ﹤0.01% | 512 |
|
|
2019
Q2 | $214K | Hold |
2,560
| – | – | 0.01% | 524 |
|
|
2019
Q1 | $202K | Buy |
+2,560
| New | +$187K | 0.01% | 515 |
|
|
2018
Q4 | – | Sell |
-2,801
| Closed | -$224K | – | 516 |
|
|
2018
Q3 | $224K | Buy |
+2,801
| New | +$209K | ﹤0.01% | 499 |
|
|
2018
Q2 | – | Sell |
-2,801
| Closed | -$215K | – | 535 |
|
|
2018
Q1 | $215K | Buy |
+2,801
| New | +$207K | ﹤0.01% | 497 |
|
|
2017
Q2 | – | Sell |
-4,061
| Closed | -$204K | – | 551 |
|
|
2017
Q1 | $204K | Hold |
4,061
| – | – | 0.01% | 541 |
|
|
2016
Q4 | $201K | Buy |
+4,061
| New | +$206K | 0.01% | 539 |
|
Other funds holding XYL
Dai-ichi Life Insurance Company's XYL Position: Q2 2026 in Review
Dai-ichi Life Insurance Company held its Xylem (XYL) position steady in Q2 2026 at 12,275 shares worth $1.45M. The position accounts for 0.03% of the portfolio, ranked #315.
Dai-ichi Life Insurance Company first reported a position in XYL in Q4 2016 and has held it in 28 quarters since. The position peaked at $13.6M in Q4 2023. 1,103 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- Dai-ichi Life Insurance Company held 12,275 shares of Xylem worth $1.45M as of Q2 2026.
- Dai-ichi Life Insurance Company left its Xylem share count unchanged in Q2 2026.
- Xylem made up 0.03% of Dai-ichi Life Insurance Company's portfolio in Q2 2026, its #315 holding.
- Dai-ichi Life Insurance Company first reported a position in Xylem in Q4 2016 and has held it in 28 quarters since.
- Dai-ichi Life Insurance Company's Xylem position peaked at $13.6M in Q4 2023.
- 1,103 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2026, filed 12 Aug 2026.